All Stories

  1. The “humanized” N‐glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus‐neutralizing antibody response in vaccinated...
  2. Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen
  3. Production of Chimeric Hepatitis B Virus Surface Antigens in Mammalian Cells
  4. N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
  5. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice
  6. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein
  7. Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination
  8. Novel function of the endoplasmic reticulum degradation-enhancing α-mannosidase-like proteins in the human hepatitis B virus life cycle, mediated by the middle envelope protein
  9. Modulation of the unfolded protein response by the human hepatitis B virus
  10. Using Proteomics to Unravel the Mysterious Steps of the HBV-Life-Cycle
  11. Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication
  12. Comparative Proteomics Reveals Novel Components at the Plasma Membrane of Differentiated HepaRG Cells and Different Distribution in Hepatocyte- and Biliary-Like Cells
  13. Regulation of Hepatitis B Virus Infection by Rab5, Rab7, and the Endolysosomal Compartment
  14. Characterization of the anti‐HBV activity of HLP1–23, a human lactoferrin‐derived peptide
  15. Caveolae-Dependent Endocytosis in Viral Infection
  16. Activation of ERAD Pathway by Human Hepatitis B Virus Modulates Viral and Subviral Particle Production
  17. Cholesterol Depletion of Hepatoma Cells Impairs Hepatitis B Virus Envelopment by Altering the Topology of the Large Envelope Protein
  18. Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells
  19. Treatment of hepatitis B virus-infected cells with α-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity
  20. Brefeldin A inhibits pestivirus release from infected cells, without affecting its assembly and infectivity
  21. Role of N-glycan trimming in the folding and secretion of the pestivirus protein Erns
  22. The pestivirus Erns glycoprotein interacts with E2 in both infected cells and mature virions
  23. Role of disulfide bond formation in the folding and assembly of the envelope glycoproteins of a pestivirus